XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 13,666 $ 16,233
General and administrative 10,920 3,701
Total operating expenses 24,586 19,934
Operating loss (24,586) (19,934)
Interest income 1,265 1,776
Other income (loss), net (82) 160
gain from change in fair value of warrant liabilities, liability 0 43,041
Net income (loss) $ (23,403) $ 25,043
Shares used in computing net income (loss) per share, basic (in shares) 48,262 43,001
Net income (loss) per share, basic (in dollars per share) $ (0.48) $ 0.58
Adjustment for change in fair value of warrant liabilities $ 0 $ (43,792)
Adjusted numerator, diluted $ (23,403) $ (18,749)
Shares used in computing net loss per share, diluted (in shares) 48,262 44,102
Net loss per share, diluted (in dollars per share) $ (0.48) $ (0.43)